Terns Pharmaceuticals, Inc. (TERN)
52.93
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
52.94
+0.02
(+0.03%)
After-Hours: 20:00
Terns Pharmaceuticals EPS Diluted (Quarterly) : -0.2395 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | -1.715 |
| Cogent Biosciences, Inc. | -0.6934 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Corcept Therapeutics, Inc. | -0.2988 |
| ADMA Biologics, Inc. | 0.2025 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.57M |
| Total Expenses (Quarterly) | 23.57M |
| Enterprise Value | 5.091B |
| Earnings Yield | -1.95% |
| Normalized Earnings Yield | -1.951 |